Enanta Pharmaceuticals reported $-22045000 in Net Income for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 3555M 3519M
Acorda Therapeutics ACOR:US $ -33.45M 49.6M
Amgen AMGN:US $ 1646M 31M
Anika Therapeutics ANIK:US $ 2.84M 18.49M
Arrowhead Research ARWR:US $ -26818000 6.09M
AstraZeneca AZN:LN 1561M 549M
Biogen BIIB:US $ 448.5M 38.3M
Bristol Myers Squibb BMY:US $ 2021M 12048M
Enanta Pharmaceuticals ENTA:US $ -22.04M 13.72M
Gilead Sciences GILD:US $ 1729M 178M
GlaxoSmithKline GSK:LN 1073M 396M
Halozyme Therapeutics HALO:US $ 27.9M 45.27M
Insmed INSM:US $ -91641000 10.57M
Intercept Pharmaceuticals ICPT:US $ -40.42M 11.73M
IONIS PHARMACEUT IONS:US $ -89.87M 250.4M
Johnson & Johnson JNJ:US $ 6278M 81M
Karyopharm Therapeutics KPTI:US $ -57414000 13.99M
Ligand Pharmaceuticals LGND:US $ 18.11M 12.34M
Marinus Pharmaceuticals MRNS:US $ -27.14M 9.67M
Merk MRK:US $ 3179M 5273M
Neurocrine Biosciences NBIX:US $ 32.1M 315.8M
Novartis NOVN:VX SF 2059M 35M
Novavax NVAX:US $ -222.72M 45.16M
Pfizer PFE:US $ 4878M 4284M
Ptc Therapeutics PTCT:US $ -128.64M 54.29M
Sarepta Therapeutics SRPT:US $ -167.25M 22.07M
Vertex Pharmaceuticals VRTX:US $ 653.14M 48.95M
Vital Therapies VTL:US $ -34.53M 23.38M
YTE INCY:US $ 53.54M 96.32M